Thus, an imbalanced thrombin generation might be a predominant contributor to the excess thromboembolic risk in patients with insulin-requiring diabetes, whereas a balanced thrombin generation could explain the comparable thromboembolic risk in those with diabetes not on insulin and no diabetes. Here, INS is linked to diabetes mellitus.